THE ROLE OF NHS ENGLAND COMMISSIONING POLICIES IN PROMOTING EQUITABLE ACCESS TO HIGH-COST DRUGS

被引：0
|
作者：
Anderson, Marina [1 ]
机构：
[1] Univ Liverpool, Univ Hosp Aintree, Dept Rheumatol, Liverpool L69 3BX, Merseyside, England
来源：
RHEUMATOLOGY | 2015年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I69
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies
    Mao, Zhifeng
    Alvarez-Gonzalez, Cesar
    Allen-Philbey, Kimberley
    De Trane, Stefania
    Yildized, Ozlem
    Campion, Tom
    Adams, Ashok
    Turnere, Benjamin P.
    Marta, Monica
    Gnanapavan, Sharmilee
    Espasandin, Maria
    Mathews, Joela
    Giovannoni, Gavin
    Baker, David
    Schmierer, Klaus
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 247 - 253
  • [22] Improving Access to High-Cost Technologies in the Asia Region
    Mundy, Linda
    Trowman, Rebecca
    Kearney, Brendon
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2019, 35 (03) : 168 - 175
  • [23] High-Cost Generic Drugs - Implications for Patients and Policymakers
    Uhl, Kathleen
    Peters, John R.
    Flanagan, Keith
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07): : 685 - 686
  • [24] High-Cost Generic Drugs - Implications for Patients and Policymakers
    Alpern, Jonathan D.
    Stauffer, William M.
    Kesselheim, Aaron S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1859 - 1862
  • [25] DEALING WITH FREQUENT CANCERS IN CHILE: IS IT REALLY THAT EXPENSIVE TO GUARANTEE ACCESS TO HIGH-COST DRUGS IN LUNG CANCER?
    Paredes, D.
    Orlandi, F.
    Lenz Alcayaga, R.
    VALUE IN HEALTH, 2019, 22 : S93 - S94
  • [26] High-Cost Generic Drugs - Implications for Patients and Policymakers Reply
    Kesselheim, Aaron S.
    Alpern, Jonathan D.
    Stauffer, William M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (07): : 686 - 686
  • [27] The Inflation Reduction Act and Access to High-Cost Cardiovascular Therapies
    Kazi, Dhruv S.
    Wadhera, Rishi K.
    Rome, Benjamin N.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (17): : 1619 - 1620
  • [28] Impact of restricting access to high-cost medications for hepatocellular carcinoma
    Ma, Yuk Ting
    Palmer, Daniel H.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (04) : 465 - 473
  • [29] A Shared Drive: Securing Patient Access to High-Cost Medicines
    van der Ent, Leendert
    HEMASPHERE, 2017, 1 (01):
  • [30] Access to high cost drugs in Australia
    Lu, CY
    Williams, K
    Day, R
    March, L
    Sansom, L
    Bertouch, J
    BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7463): : 415 - 416
12345